FOLH1 and glioblastoma: Moreau et al. echoed these concerns in their case report of a GBM patient with modest 68Ga-PSMA-11 (HBED-CC) uptake (SUVmax of 3.2), who was determined to have postradiation changes based on clinical imaging [48].